BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 18607402)

  • 1. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on pathophysiology and treatment of diabetic kidney disease.
    Satirapoj B
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S228-41. PubMed ID: 21280541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R; Nangaku M; Miyata T
    Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy.
    Elseweidy MM; Elswefy SE; Younis NN; Zaghloul MS
    Exp Biol Med (Maywood); 2013 Aug; 238(8):881-8. PubMed ID: 23970406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy: important pathophysiologic mechanisms.
    Soldatos G; Cooper ME
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S75-9. PubMed ID: 18994672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy.
    Palm F
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):997-1001. PubMed ID: 17002679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy.
    Sharma K; Ziyadeh FN
    Semin Nephrol; 1997 Mar; 17(2):80-92. PubMed ID: 9148380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy--predictive methods].
    Ouchi H; Isogai S
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():288-93. PubMed ID: 12430243
    [No Abstract]   [Full Text] [Related]  

  • 15. Microvascular basement membranes in diabetes mellitus.
    Tsilibary EC
    J Pathol; 2003 Jul; 200(4):537-46. PubMed ID: 12845621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy in childhood and adolescents.
    Chiarelli F; Casani A; Tumini S; Kordonouri O; Danne T
    Diabetes Nutr Metab; 1999 Apr; 12(2):144-53. PubMed ID: 10554897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression mechanisms and incident factors of diabetic nephropathy].
    Fujita T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():275-80. PubMed ID: 12430241
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.